View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsFONAR 将来の成長Future 基準チェック /06現在、 FONARの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Medical Equipment 収益成長13.3%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 03+ 3 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap Indexお知らせ • May 06FONAR Corporation, Annual General Meeting, Jun 17, 2026FONAR Corporation, Annual General Meeting, Jun 17, 2026. Location: at the hilton long island huntington hotel, 598 broadholow road, melvile, new york 11747, United Statesお知らせ • Feb 10FONAR Corporation announced delayed 10-Q filingOn 02/09/2026, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.New Risk • Dec 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (€81.8m market cap, or US$96.0m).Buy Or Sell Opportunity • Dec 31Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to €15.60. The fair value is estimated to be €12.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.6% over the last 3 years. Earnings per share has declined by 7.2%.お知らせ • Sep 13FONAR Corporation announced delayed annual 10-K filingOn 09/12/2025, FONAR Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jul 10Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR).Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR) on July 7, 2025. The Proposed Acquisition Group currently beneficially owns approximately 5.01% of the outstanding FONAR Stock. The Board of Directors of FONAR Corporation formed a special committee consisting of independent and disinterested directors of the Board, who will carefully review the proposal to determine the course of action that is in the best interests of FONAR Corporation and all shareholders.お知らせ • Jul 03FONAR Corporation Appoints Robert M. Carrino as an Independent DirectorFONAR Corporation announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the company’s board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position. Mr. Carrino is a partner at CFGI, LLC in New York City, where he leads the firm’s SPAC practice. He provides complex accounting and consulting services to both public and private companies. Prior to joining CFGI, Mr. Carrino was an audit manager at KPMG, LLP’s Metro New York Long Island Office. Mr. Carrino, a Certified Public Accountant, earned the degree of Bachelor of Science in Business Administration with a concentration in accounting from Western New England University.お知らせ • Jun 25FONAR Corporation Announces Intention of Claudette J.V. Chan to Retire from the Board of Directors and Secretary, Effective June 19, 2025On June 18, 2025, Claudette J.V. Chan, a member of the Board of Directors and the Secretary of FONAR Corporation, notified the Company of her intention to retire from the Company's Board of Directors, and to retire as Secretary of the Company, effective June 19, 2025. Ms. Chan did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.お知らせ • Apr 23FONAR Corporation, Annual General Meeting, May 19, 2025FONAR Corporation, Annual General Meeting, May 19, 2025. Location: hilton long island huntington hotel, 598 broadhollow road, melville, new york 11747, United Statesお知らせ • Feb 15FONAR Corporation announced delayed 10-Q filingOn 02/14/2025, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Reported Earnings • Nov 15First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: US$25.0m (down 3.4% from 1Q 2024). Net income: US$3.14m (down 20% from 1Q 2024). Profit margin: 13% (down from 15% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.7m (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.5% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€89.7m market cap, or US$98.1m).New Risk • Oct 01New major risk - Revenue and earnings growthEarnings have declined by 3.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.Reported Earnings • Sep 29Full year 2024 earnings released: EPS: US$1,637 (vs US$1,425 in FY 2023)Full year 2024 results: EPS: US$1,637 (up from US$1,425 in FY 2023). Revenue: US$102.9b (up 4.3% from FY 2023). Net income: US$10.6b (up 13% from FY 2023). Profit margin: 10% (in line with FY 2023). Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.お知らせ • Sep 28FONAR Corporation to Report Fiscal Year 2024 Results on Sep 27, 2024FONAR Corporation announced that they will report fiscal year 2024 results on Sep 27, 2024Reported Earnings • May 17Third quarter 2024 earnings released: EPS: US$0.28 (vs US$0.55 in 3Q 2023)Third quarter 2024 results: EPS: US$0.28 (down from US$0.55 in 3Q 2023). Revenue: US$25.7m (up 1.2% from 3Q 2023). Net income: US$1.87m (down 49% from 3Q 2023). Profit margin: 7.3% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 1% per year.お知らせ • Apr 09FONAR Corporation, Annual General Meeting, May 20, 2024FONAR Corporation, Annual General Meeting, May 20, 2024, at 10:00 US Eastern Standard Time. Location: The Hilton Long Island Huntington Hotel, 598 Broadhollow Road, Melville New York United States Agenda: To elect five Directors to the Board of Directors; to approve, on an advisory basis, the compensation of the Company’s named executive officers; to recommend, on an advisory basis, whether the advisory stockholder vote to approve the compensation of the Company’s named executive officers be taken every year, every two years, or every three years; to ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2024; and to transact such other business as may properly come before the meeting.Reported Earnings • Feb 16Second quarter 2024 earnings released: EPS: US$0.59 (vs US$0.32 in 2Q 2023)Second quarter 2024 results: EPS: US$0.59 (up from US$0.32 in 2Q 2023). Revenue: US$25.4m (up 4.7% from 2Q 2023). Net income: US$3.76m (up 76% from 2Q 2023). Profit margin: 15% (up from 8.8% in 2Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.Reported Earnings • Nov 16First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: US$25.8m (up 11% from 1Q 2023). Net income: US$4.11m (up 110% from 1Q 2023). Profit margin: 16% (up from 8.4% in 1Q 2023). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Nov 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €14.90, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 30x in the Medical Equipment industry in Germany. Total loss to shareholders of 9.1% over the past three years.New Risk • Oct 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €95.3m (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€95.3m market cap, or US$100.0m).Reported Earnings • Sep 29Full year 2023 earnings released: EPS: US$1.37 (vs US$1.78 in FY 2022)Full year 2023 results: EPS: US$1.37 (down from US$1.78 in FY 2022). Revenue: US$98.6m (up 1.1% from FY 2022). Net income: US$9.38m (down 21% from FY 2022). Profit margin: 9.5% (down from 12% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Reported Earnings • May 16Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: US$25.4m (up 3.5% from 3Q 2022). Net income: US$3.69m (up 69% from 3Q 2022). Profit margin: 14% (up from 8.9% in 3Q 2022). The increase in margin was primarily driven by higher revenue.Reported Earnings • Feb 15Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.57 in 2Q 2022)Second quarter 2023 results: EPS: US$0.34 (down from US$0.57 in 2Q 2022). Revenue: US$24.3m (flat on 2Q 2022). Net income: US$2.23m (down 42% from 2Q 2022). Profit margin: 9.2% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 3% per year.Reported Earnings • Nov 16First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$23.2m (down 2.3% from 1Q 2022). Net income: US$2.05m (down 45% from 1Q 2022). Profit margin: 8.8% (down from 16% in 1Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.Recent Insider Transactions • Oct 05Key Executive recently bought €67k worth of stockOn the 30th of September, Luciano Bonanni bought around 5k shares on-market at roughly €14.34 per share. This transaction amounted to 9.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Luciano's only on-market trade for the last 12 months.お知らせ • Sep 30FONAR Corporation (NasdaqCM:FONR) announces an Equity Buyback for $9 million worth of its shares.FONAR Corporation (NasdaqCM:FONR) announces a share repurchase program. Under the program, the company will repurchase its own shares. The program has no expiration date. On September 26, 2022, the company announced that the Board of Directors has approved up to $9 million to be repurchased under the program.Reported Earnings • Sep 29Full year 2022 earnings released: EPS: US$1.71 (vs US$1.46 in FY 2021)Full year 2022 results: EPS: US$1.71 (up from US$1.46 in FY 2021). Revenue: US$97.6m (up 8.5% from FY 2021). Net income: US$11.9m (up 22% from FY 2021). Profit margin: 12% (up from 11% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.お知らせ • Aug 13FONAR Corporation Announces Passing of Its Chairman of the Board of Directors, Raymond V. DamadianFonar Corporation and it’s board of directors reported the passing of its Chairman of the Board of Directors, Raymond V. Damadian, on August 3, 2022. Highlights of the life of Dr. Raymond Damadian: Founded FONAR Corporation (1978), the first company in the MRI industry, maker of the QED80, the world’s first MRI scanner (1980); Conceived the idea for MRI in 1969; Made the discovery in 1970 that is the basis for the making of every MRI image ever produced, the foundation of the MRI industry. Dr. Damadian discovered that there is a marked difference in the relaxation times of NMR (MRI) signals from normal and cancerous tissues of the same type, as well as from different types of normal tissues. This discovery, published in the peer-reviewed journal ‘Science’ in March 1971 marked the beginning of the MRI industry.; Awarded the world’s first MRI patent (filed in March 1971). This patent was upheld in FONAR’s successful lawsuit against General Electric in 1995.; Built the world’s first MRI scanner, Indomitable, which produced the world’s first MRI scan on July 3, 1977.; Awarded The National Medal of Technology by President Ronald Reagan in 1988.; Inducted into the National Inventors Hall of Fame in 1989, joining a select group of renowned pioneers, including Orville and Wilbur Wright, Henry Ford, Thomas Edison and Alexander Graham Bell. Received the Excellence in Medicine award from the Chiari & Syringomyelia Foundation (CSF) in London England on November 10, 2018.Reported Earnings • May 17Third quarter 2022 earnings released: EPS: US$0.33 (vs US$0.55 in 3Q 2021)Third quarter 2022 results: EPS: US$0.33 (down from US$0.55 in 3Q 2021). Revenue: US$24.6m (up 6.4% from 3Q 2021). Net income: US$2.19m (down 41% from 3Q 2021). Profit margin: 8.9% (down from 16% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.お知らせ • Apr 09FONAR Corporation, Annual General Meeting, May 23, 2022FONAR Corporation, Annual General Meeting, May 23, 2022. Location: Double Tree Hotel, Wilmington Downtown, 700 King Street, Wilmington, Delaware 19801 (302-655-0400) New York United States Agenda: To elect five Directors to the Board of Directors; To approve, on an advisory basis, the compensation of the Company’s named executive officers; To ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2022; To transact such other business as may properly come before the meeting.Buying Opportunity • Mar 12Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be US$19.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 27% per annum over the last 3 years.Reported Earnings • Feb 15Second quarter 2022 earnings: Revenues in line with analyst expectationsSecond quarter 2022 results: Revenue: US$24.5m (up 16% from 2Q 2021). Net income: US$3.84m (up 29% from 2Q 2021). Profit margin: 16% (up from 14% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Reported Earnings • Sep 29Full year 2021 earnings released: EPS US$1.51 (vs US$1.20 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$89.9m (up 4.9% from FY 2020). Net income: US$10.2m (up 30% from FY 2020). Profit margin: 11% (up from 9.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.お知らせ • Jun 28+ 8 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive IndexReported Earnings • May 15Third quarter 2021 earnings released: EPS US$0.53 (vs US$0.18 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$23.1m (up 6.5% from 3Q 2020). Net income: US$3.69m (up 207% from 3Q 2020). Profit margin: 16% (up from 5.6% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Mar 03New 90-day high: €16.60The company is up 5.0% from its price of €15.80 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 16% over the same period.Reported Earnings • Feb 19Second quarter 2021 earnings released: EPS US$0.43 (vs US$0.45 in 2Q 2020)The company reported a soft second quarter result with weaker revenues, although earnings and profit margins were flat. Second quarter 2021 results: Revenue: US$21.2m (down 1.3% from 2Q 2020). Net income: US$2.97m (flat on 2Q 2020). Profit margin: 14% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Dec 29New 90-day low: €14.00The company is down 25% from its price of €18.60 on 30 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 10.0% over the same period.お知らせ • Sep 30FONAR Corporation announced delayed amended 10-K filingOn 09/29/2020, FONAR Corporation announced that they will be unable to file their amended 10-K by the deadline required by the SEC.Reported Earnings • Sep 29Full year earnings released - EPS €1.20Over the last 12 months the company has reported total profits of US$7.86m, down 46% from the prior year. Total revenue was US$85.7m over the last 12 months, down 1.7% from the prior year. Profit margins were 9.2%, which is lower than the 17% margin from last year. The decrease in margin was primarily driven by higher expenses. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、FONAR は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:FOAA - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026105648N/A12/31/2025106759N/A9/30/20251057711N/A6/30/20251048711N/A3/31/20251038812N/A12/31/20241027811N/A9/30/202410291113N/A6/30/2024103101314N/A3/31/2024103101314N/A12/31/2023102121215N/A9/30/2023101111114N/A6/30/20239991014N/A3/31/202398101115N/A12/31/20229781115N/A9/30/202297101217N/A6/30/202298121115N/A3/31/202297101216N/A12/31/202196121115N/A9/30/202193111117N/A6/30/202190101419N/A3/31/202186101420N/A12/31/20208571520N/A9/30/20208571420N/A6/30/20208681320N/A3/31/202087121320N/A12/31/20198814N/A20N/A9/30/20198815N/A20N/A6/30/20198715N/A19N/A3/31/20199120N/A19N/A12/31/20189419N/A20N/A9/30/20189720N/A19N/A6/30/20189920N/A19N/A3/31/20189916N/A20N/A12/31/20179719N/A19N/A9/30/20179519N/A17N/A6/30/20179419N/A17N/A3/31/20179219N/A16N/A12/31/20169016N/A15N/A9/30/20168916N/A17N/A6/30/20168815N/A17N/A3/31/20168614N/A15N/A12/31/20158313N/A15N/A9/30/20158213N/A14N/A6/30/20158212N/A13N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: FOAAの予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: FOAAの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: FOAAの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: FOAAの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: FOAAの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: FOAAの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/04 13:13終値2026/06/02 00:00収益2026/03/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋FONAR Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 03+ 3 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell Microcap Index
お知らせ • May 06FONAR Corporation, Annual General Meeting, Jun 17, 2026FONAR Corporation, Annual General Meeting, Jun 17, 2026. Location: at the hilton long island huntington hotel, 598 broadholow road, melvile, new york 11747, United States
お知らせ • Feb 10FONAR Corporation announced delayed 10-Q filingOn 02/09/2026, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
New Risk • Dec 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (€81.8m market cap, or US$96.0m).
Buy Or Sell Opportunity • Dec 31Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to €15.60. The fair value is estimated to be €12.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.6% over the last 3 years. Earnings per share has declined by 7.2%.
お知らせ • Sep 13FONAR Corporation announced delayed annual 10-K filingOn 09/12/2025, FONAR Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jul 10Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR).Timothy Damadian along with management team and Board of Directors of FONAR Corporation and third parties proposed to acquire remaining 94.99% stake in FONAR Corporation (NasdaqCM:FONR) on July 7, 2025. The Proposed Acquisition Group currently beneficially owns approximately 5.01% of the outstanding FONAR Stock. The Board of Directors of FONAR Corporation formed a special committee consisting of independent and disinterested directors of the Board, who will carefully review the proposal to determine the course of action that is in the best interests of FONAR Corporation and all shareholders.
お知らせ • Jul 03FONAR Corporation Appoints Robert M. Carrino as an Independent DirectorFONAR Corporation announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the company’s board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position. Mr. Carrino is a partner at CFGI, LLC in New York City, where he leads the firm’s SPAC practice. He provides complex accounting and consulting services to both public and private companies. Prior to joining CFGI, Mr. Carrino was an audit manager at KPMG, LLP’s Metro New York Long Island Office. Mr. Carrino, a Certified Public Accountant, earned the degree of Bachelor of Science in Business Administration with a concentration in accounting from Western New England University.
お知らせ • Jun 25FONAR Corporation Announces Intention of Claudette J.V. Chan to Retire from the Board of Directors and Secretary, Effective June 19, 2025On June 18, 2025, Claudette J.V. Chan, a member of the Board of Directors and the Secretary of FONAR Corporation, notified the Company of her intention to retire from the Company's Board of Directors, and to retire as Secretary of the Company, effective June 19, 2025. Ms. Chan did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.
お知らせ • Apr 23FONAR Corporation, Annual General Meeting, May 19, 2025FONAR Corporation, Annual General Meeting, May 19, 2025. Location: hilton long island huntington hotel, 598 broadhollow road, melville, new york 11747, United States
お知らせ • Feb 15FONAR Corporation announced delayed 10-Q filingOn 02/14/2025, FONAR Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Reported Earnings • Nov 15First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: US$25.0m (down 3.4% from 1Q 2024). Net income: US$3.14m (down 20% from 1Q 2024). Profit margin: 13% (down from 15% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.
New Risk • Oct 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €89.7m (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.5% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€89.7m market cap, or US$98.1m).
New Risk • Oct 01New major risk - Revenue and earnings growthEarnings have declined by 3.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
Reported Earnings • Sep 29Full year 2024 earnings released: EPS: US$1,637 (vs US$1,425 in FY 2023)Full year 2024 results: EPS: US$1,637 (up from US$1,425 in FY 2023). Revenue: US$102.9b (up 4.3% from FY 2023). Net income: US$10.6b (up 13% from FY 2023). Profit margin: 10% (in line with FY 2023). Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
お知らせ • Sep 28FONAR Corporation to Report Fiscal Year 2024 Results on Sep 27, 2024FONAR Corporation announced that they will report fiscal year 2024 results on Sep 27, 2024
Reported Earnings • May 17Third quarter 2024 earnings released: EPS: US$0.28 (vs US$0.55 in 3Q 2023)Third quarter 2024 results: EPS: US$0.28 (down from US$0.55 in 3Q 2023). Revenue: US$25.7m (up 1.2% from 3Q 2023). Net income: US$1.87m (down 49% from 3Q 2023). Profit margin: 7.3% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 1% per year.
お知らせ • Apr 09FONAR Corporation, Annual General Meeting, May 20, 2024FONAR Corporation, Annual General Meeting, May 20, 2024, at 10:00 US Eastern Standard Time. Location: The Hilton Long Island Huntington Hotel, 598 Broadhollow Road, Melville New York United States Agenda: To elect five Directors to the Board of Directors; to approve, on an advisory basis, the compensation of the Company’s named executive officers; to recommend, on an advisory basis, whether the advisory stockholder vote to approve the compensation of the Company’s named executive officers be taken every year, every two years, or every three years; to ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2024; and to transact such other business as may properly come before the meeting.
Reported Earnings • Feb 16Second quarter 2024 earnings released: EPS: US$0.59 (vs US$0.32 in 2Q 2023)Second quarter 2024 results: EPS: US$0.59 (up from US$0.32 in 2Q 2023). Revenue: US$25.4m (up 4.7% from 2Q 2023). Net income: US$3.76m (up 76% from 2Q 2023). Profit margin: 15% (up from 8.8% in 2Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.
Reported Earnings • Nov 16First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: US$25.8m (up 11% from 1Q 2023). Net income: US$4.11m (up 110% from 1Q 2023). Profit margin: 16% (up from 8.4% in 1Q 2023). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Nov 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €14.90, the stock trades at a trailing P/E ratio of 12x. Average trailing P/E is 30x in the Medical Equipment industry in Germany. Total loss to shareholders of 9.1% over the past three years.
New Risk • Oct 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €95.3m (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€95.3m market cap, or US$100.0m).
Reported Earnings • Sep 29Full year 2023 earnings released: EPS: US$1.37 (vs US$1.78 in FY 2022)Full year 2023 results: EPS: US$1.37 (down from US$1.78 in FY 2022). Revenue: US$98.6m (up 1.1% from FY 2022). Net income: US$9.38m (down 21% from FY 2022). Profit margin: 9.5% (down from 12% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Reported Earnings • May 16Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: US$25.4m (up 3.5% from 3Q 2022). Net income: US$3.69m (up 69% from 3Q 2022). Profit margin: 14% (up from 8.9% in 3Q 2022). The increase in margin was primarily driven by higher revenue.
Reported Earnings • Feb 15Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.57 in 2Q 2022)Second quarter 2023 results: EPS: US$0.34 (down from US$0.57 in 2Q 2022). Revenue: US$24.3m (flat on 2Q 2022). Net income: US$2.23m (down 42% from 2Q 2022). Profit margin: 9.2% (down from 16% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 3% per year.
Reported Earnings • Nov 16First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$23.2m (down 2.3% from 1Q 2022). Net income: US$2.05m (down 45% from 1Q 2022). Profit margin: 8.8% (down from 16% in 1Q 2022). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 3% per year.
Recent Insider Transactions • Oct 05Key Executive recently bought €67k worth of stockOn the 30th of September, Luciano Bonanni bought around 5k shares on-market at roughly €14.34 per share. This transaction amounted to 9.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Luciano's only on-market trade for the last 12 months.
お知らせ • Sep 30FONAR Corporation (NasdaqCM:FONR) announces an Equity Buyback for $9 million worth of its shares.FONAR Corporation (NasdaqCM:FONR) announces a share repurchase program. Under the program, the company will repurchase its own shares. The program has no expiration date. On September 26, 2022, the company announced that the Board of Directors has approved up to $9 million to be repurchased under the program.
Reported Earnings • Sep 29Full year 2022 earnings released: EPS: US$1.71 (vs US$1.46 in FY 2021)Full year 2022 results: EPS: US$1.71 (up from US$1.46 in FY 2021). Revenue: US$97.6m (up 8.5% from FY 2021). Net income: US$11.9m (up 22% from FY 2021). Profit margin: 12% (up from 11% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.
お知らせ • Aug 13FONAR Corporation Announces Passing of Its Chairman of the Board of Directors, Raymond V. DamadianFonar Corporation and it’s board of directors reported the passing of its Chairman of the Board of Directors, Raymond V. Damadian, on August 3, 2022. Highlights of the life of Dr. Raymond Damadian: Founded FONAR Corporation (1978), the first company in the MRI industry, maker of the QED80, the world’s first MRI scanner (1980); Conceived the idea for MRI in 1969; Made the discovery in 1970 that is the basis for the making of every MRI image ever produced, the foundation of the MRI industry. Dr. Damadian discovered that there is a marked difference in the relaxation times of NMR (MRI) signals from normal and cancerous tissues of the same type, as well as from different types of normal tissues. This discovery, published in the peer-reviewed journal ‘Science’ in March 1971 marked the beginning of the MRI industry.; Awarded the world’s first MRI patent (filed in March 1971). This patent was upheld in FONAR’s successful lawsuit against General Electric in 1995.; Built the world’s first MRI scanner, Indomitable, which produced the world’s first MRI scan on July 3, 1977.; Awarded The National Medal of Technology by President Ronald Reagan in 1988.; Inducted into the National Inventors Hall of Fame in 1989, joining a select group of renowned pioneers, including Orville and Wilbur Wright, Henry Ford, Thomas Edison and Alexander Graham Bell. Received the Excellence in Medicine award from the Chiari & Syringomyelia Foundation (CSF) in London England on November 10, 2018.
Reported Earnings • May 17Third quarter 2022 earnings released: EPS: US$0.33 (vs US$0.55 in 3Q 2021)Third quarter 2022 results: EPS: US$0.33 (down from US$0.55 in 3Q 2021). Revenue: US$24.6m (up 6.4% from 3Q 2021). Net income: US$2.19m (down 41% from 3Q 2021). Profit margin: 8.9% (down from 16% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 09FONAR Corporation, Annual General Meeting, May 23, 2022FONAR Corporation, Annual General Meeting, May 23, 2022. Location: Double Tree Hotel, Wilmington Downtown, 700 King Street, Wilmington, Delaware 19801 (302-655-0400) New York United States Agenda: To elect five Directors to the Board of Directors; To approve, on an advisory basis, the compensation of the Company’s named executive officers; To ratify the selection of Marcum LLP as the Company’s auditors for the fiscal year ending June 30, 2022; To transact such other business as may properly come before the meeting.
Buying Opportunity • Mar 12Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be US$19.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 27% per annum over the last 3 years.
Reported Earnings • Feb 15Second quarter 2022 earnings: Revenues in line with analyst expectationsSecond quarter 2022 results: Revenue: US$24.5m (up 16% from 2Q 2021). Net income: US$3.84m (up 29% from 2Q 2021). Profit margin: 16% (up from 14% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Reported Earnings • Sep 29Full year 2021 earnings released: EPS US$1.51 (vs US$1.20 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$89.9m (up 4.9% from FY 2020). Net income: US$10.2m (up 30% from FY 2020). Profit margin: 11% (up from 9.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 28+ 8 more updatesFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive IndexFONAR Corporation(NasdaqCM:FONR) dropped from Russell 2000 Defensive Index
Reported Earnings • May 15Third quarter 2021 earnings released: EPS US$0.53 (vs US$0.18 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$23.1m (up 6.5% from 3Q 2020). Net income: US$3.69m (up 207% from 3Q 2020). Profit margin: 16% (up from 5.6% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Mar 03New 90-day high: €16.60The company is up 5.0% from its price of €15.80 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 16% over the same period.
Reported Earnings • Feb 19Second quarter 2021 earnings released: EPS US$0.43 (vs US$0.45 in 2Q 2020)The company reported a soft second quarter result with weaker revenues, although earnings and profit margins were flat. Second quarter 2021 results: Revenue: US$21.2m (down 1.3% from 2Q 2020). Net income: US$2.97m (flat on 2Q 2020). Profit margin: 14% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Dec 29New 90-day low: €14.00The company is down 25% from its price of €18.60 on 30 September 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 10.0% over the same period.
お知らせ • Sep 30FONAR Corporation announced delayed amended 10-K filingOn 09/29/2020, FONAR Corporation announced that they will be unable to file their amended 10-K by the deadline required by the SEC.
Reported Earnings • Sep 29Full year earnings released - EPS €1.20Over the last 12 months the company has reported total profits of US$7.86m, down 46% from the prior year. Total revenue was US$85.7m over the last 12 months, down 1.7% from the prior year. Profit margins were 9.2%, which is lower than the 17% margin from last year. The decrease in margin was primarily driven by higher expenses.